학술논문

Contribution of inflammasome complex in inflammatory-related eye disorders and its implications for anti-inflammasome therapy.
Document Type
Article
Source
Immunopharmacology & Immunotoxicology. Oct2020, Vol. 42 Issue 5, p400-407. 8p.
Subject
*NLRP3 protein
*RETINAL diseases
*DIABETIC retinopathy
*RETINAL degeneration
*DISEASES
*INTERLEUKIN-18
*RHODOPSIN
Language
ISSN
0892-3973
Abstract
Inflammasome complex is regarded as a major molecular regulator that exerts a significant function in caspase-1 activation and consequently, the development of cytokines like interleukin-1β (IL-1β) and interleukin-18 (IL-18). The secretion of these cytokines may induce inflammation. The role of inflammasomes in the pathologic process of eye-related illnesses like glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy has been well studied over the past decade. However, the detailed pathogenic mechanism of inflammasomes in these retinal diseases is still unknown. Therefore, further investigation and understanding various aspects of inflammasome complexes as well as their pivotal roles in the immunopathology of human ocular illnesses are essential. The present review aims to describe the significant involvement of inflammasomes in the immunopathology of important inflammatory retinal illnesses, including glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy focusing on anti-inflammasome therapy as a promising approach in the treatment of inflammation-related eye diseases. [ABSTRACT FROM AUTHOR]